India
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.58 B
|
March 31, 2024 | USD 13.57 | -0.25% |
|
India |
|
2 |
USD 940.89 M
|
March 31, 2024 | USD 17.54 | 2.44% |
|
India |
|
3 |
USD 402.71 M
|
March 31, 2024 | USD 18.21 | -3.37% |
|
India |
|
4 |
USD 213.12 M
|
March 31, 2024 | USD 25.14 | -2.56% |
|
India |
|
5 |
USD 100.95 M
|
March 31, 2024 | USD 4.72 | -3.66% |
|
India |
|
6 |
USD 38.33 M
|
March 31, 2024 | USD 11.74 | -1.33% |
|
India |
|
7 |
USD 34.98 M
|
March 31, 2024 | USD 21.37 | -1.96% |
|
India |
The Vaccines company in India with the highest Shareholders' Equity is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD 3.58 B.
The Vaccines company in India with the lowest Shareholders' Equity is Hester Biosciences Limited (NSE: HESTERBIO.NS) at USD 34.98 M.
The top 10 Vaccines companies in India by Shareholders' Equity are Aurobindo Pharma Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, GlaxoSmithKline Pharmaceuticals Limited, Panacea Biotec Limited, Vimta Labs Limited and Hester Biosciences Limited.
The bottom 10 Vaccines companies in India by Shareholders' Equity are Hester Biosciences Limited, Vimta Labs Limited, Panacea Biotec Limited, GlaxoSmithKline Pharmaceuticals Limited, Wockhardt Limited, Glenmark Pharmaceuticals Limited and Aurobindo Pharma Limited.